Literature DB >> 18477618

Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.

Richard I G Holt1.   

Abstract

Hyperprolactinaemia is the commonest endocrine disorder of the hypothalamic-pituitary axis and can lead to both short-term sexual dysfunction and galactorrhoea, and long-term loss of bone mineral density. Prolactin is secreted from the anterior pituitary gland under the influence of dopamine, which exerts a tonic inhibitory effect on prolactin secretion. Physiological regulators of prolactin secretion include many different types of 'stress' and sleep. Disruption of the normal control of prolactin secretion results in hyperprolactinaemia from pathological and pharmacological causes. The administration of antipsychotic medication is responsible for the high prevalence of hyperprolactinaemia in people with severe mental illness. Physiological hyperprolactinaemia, such as pregnancy and lactation, should be distinguished from pathological causes to prevent unnecessary investigation and treatment. The causes, consequences and management of hyperprolactinaemia are discussed in this article.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477618     DOI: 10.1177/0269881107087951

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  9 in total

1.  How does this happen? Part I: mechanisms of adverse drug reactions associated with psychotropic medications.

Authors:  Dean Elbe; Robert Savage
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-02

Review 2.  Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management.

Authors:  Flora Coker; David Taylor
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

3.  Unusually high prolactin level for medication-induced hyperprolactinemia: a case report.

Authors:  Emin M Akbas; Adem Gungor; Cigdem Ozdemir; Habib Bilen
Journal:  Eurasian J Med       Date:  2013-06

Review 4.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

5.  New insights in the management of antipsychotics in the treatment of schizophrenia in a patient with prolactinoma: a case report and review of the literature.

Authors:  Elvis Henrique Santos Andrade; Pedro Mario Pan; Paula F Ramalho da Silva; Ary Gadelha
Journal:  Case Rep Med       Date:  2010-11-10

6.  Nipple Eczema Causing Galactorrhea by Reactive Hyperprolactinemia, Complicated by a Galactocele.

Authors:  Kevin Chassain; Arthur Vrignaud; Elise Cesbron; Corina Bara-Passot; Hervé Maillard
Journal:  Eur J Breast Health       Date:  2021-12-30

7.  High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury.

Authors:  Charles W Wilkinson; Kathleen F Pagulayan; Eric C Petrie; Cynthia L Mayer; Elizabeth A Colasurdo; Jane B Shofer; Kim L Hart; David Hoff; Matthew A Tarabochia; Elaine R Peskind
Journal:  Front Neurol       Date:  2012-02-07       Impact factor: 4.003

8.  Improving physical health monitoring for patients with chronic mental health problems who receive antipsychotic medications.

Authors:  Nihad Abdallah; Rory Conn; Abdel Latif Marini
Journal:  BMJ Qual Improv Rep       Date:  2016-07-29

9.  Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion.

Authors:  Tanja Veselinović; Ingo Vernaleken; Paul Cumming; Uwe Henning; Lina Winkler; Peter Kaleta; Michael Paulzen; Christian Luckhaus; Gerhard Gründer
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-27       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.